Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88075702
Filing Date: 08/13/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER88075702
MARK INFORMATION
*MARK\\TICRS\EXPORT17\IMAGEOUT 17\880\757\88075702\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENTAIONCO
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) blue, teal, orange, and red is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a circle which is circumscribed appearing next to the word "AIONCO" in a stylized font resembling a DNA sequence in orange and red color. Within the ring of the circle are other circles layered together with colors blue and teal. The background is transparent. White is not claimed as a color of the mark.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT1266 x 372
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARKGene Lee
INTERNAL ADDRESSUnit 421
*STREET151 El Camino Real
*CITYSan Jose
*STATE
(Required for U.S. applicants)
California
*COUNTRYUnited States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94030
PHONE650-318-6107
EMAIL ADDRESSXXXX
LEGAL ENTITY INFORMATION
TYPEindividual
COUNTRY OF CITIZENSHIP United States
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS009 
*IDENTIFICATIONProviding downloadable software and mobile applications for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating local databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping
FILING BASISSECTION 1(b)
INTERNATIONAL CLASS010 
*IDENTIFICATIONMedical testing and treatment products and kits in the form of modified immune cells and treatment therapies, test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens, for genomic sequencing and detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer
FILING BASISSECTION 1(b)
INTERNATIONAL CLASS042 
*IDENTIFICATIONProviding online non-downloadable software and software programs for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping
FILING BASISSECTION 1(b)
INTERNATIONAL CLASS044 
*IDENTIFICATIONProviding medical diagnostic and treatment services, namely tumor detection in the form of a liquid biopsy; tumor analysis, diagnostic, and identification in the form of sequenced tissue and identification, and tumor treatment therapy in the form of identification of appropriate combination of mutations for targeted cancers and identification of appropriate treatments targeted for those combination of mutations via modified T-cells or other treatments to inhibit expressions of those combination of mutations or to modify one or more of the mutations in the combination
FILING BASISSECTION 1(b)
ATTORNEY INFORMATION
NAME Don Reeve
ATTORNEY DOCKET NUMBER 68-T002
FIRM NAME Perspectives Law Group
INTERNAL ADDRESS Suite 206
STREET 3150 De La Cruz Blvd.
CITY Santa Clara
STATE California
COUNTRY United States
ZIP/POSTAL CODE 95054
PHONE 408-512-1907
FAX 408-512-1911
EMAIL ADDRESS donr@perspectiveslaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
CORRESPONDENCE INFORMATION
NAME Don Reeve
FIRM NAMEPerspectives Law Group
INTERNAL ADDRESS Suite 206
STREET3150 De La Cruz Blvd.
CITYSanta Clara
STATECalifornia
COUNTRYUnited States
ZIP/POSTAL CODE95054
PHONE 408-512-1907
FAX 408-512-1911
*EMAIL ADDRESSdonr@perspectiveslaw.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTIONTEAS RF
NUMBER OF CLASSES4
APPLICATION FOR REGISTRATION PER CLASS275
*TOTAL FEE DUE1100
*TOTAL FEE PAID1100
SIGNATURE INFORMATION
SIGNATURE /Don Reeve/
SIGNATORY'S NAME Don Reeve
SIGNATORY'S POSITION Attorney of Record, California Bar member
SIGNATORY'S PHONE NUMBER 408-512-1907
DATE SIGNED 08/13/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88075702
Filing Date: 08/13/2018

To the Commissioner for Trademarks:

MARK: AIONCO (stylized and/or with design, see mark)

The literal element of the mark consists of AIONCO.
The color(s) blue, teal, orange, and red is/are claimed as a feature of the mark. The mark consists of a circle which is circumscribed appearing next to the word "AIONCO" in a stylized font resembling a DNA sequence in orange and red color. Within the ring of the circle are other circles layered together with colors blue and teal. The background is transparent. White is not claimed as a color of the mark.
The applicant, Gene Lee, a citizen of United States, having an address of
      Unit 421
      151 El Camino Real
      San Jose, California 94030
      United States
      650-318-6107(phone)
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 009:  Providing downloadable software and mobile applications for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating local databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 010:  Medical testing and treatment products and kits in the form of modified immune cells and treatment therapies, test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens, for genomic sequencing and detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 042:  Providing online non-downloadable software and software programs for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 044:  Providing medical diagnostic and treatment services, namely tumor detection in the form of a liquid biopsy; tumor analysis, diagnostic, and identification in the form of sequenced tissue and identification, and tumor treatment therapy in the form of identification of appropriate combination of mutations for targeted cancers and identification of appropriate treatments targeted for those combination of mutations via modified T-cells or other treatments to inhibit expressions of those combination of mutations or to modify one or more of the mutations in the combination
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The applicant's current Attorney Information:
      Don Reeve of Perspectives Law Group
      Suite 206
      3150 De La Cruz Blvd.
      Santa Clara, California 95054
      United States
      408-512-1907(phone)
      408-512-1911(fax)
      donr@perspectiveslaw.com (authorized)
The attorney docket/reference number is 68-T002.

The applicant's current Correspondence Information:
      Don Reeve
      Perspectives Law Group
      Suite 206
      3150 De La Cruz Blvd.
      Santa Clara, California 95054
      408-512-1907(phone)
      408-512-1911(fax)
      donr@perspectiveslaw.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $1100 has been submitted with the application, representing payment for 4 class(es).

Declaration

Declaration Signature

Signature: /Don Reeve/   Date: 08/13/2018
Signatory's Name: Don Reeve
Signatory's Position: Attorney of Record, California Bar member
Payment Sale Number: 88075702
Payment Accounting Date: 08/13/2018

Serial Number: 88075702
Internet Transmission Date: Mon Aug 13 12:07:32 EDT 2018
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-201808131207329
12599-88075702-610dc384cf1363baaf90e5f29
b474bb6b7d7ef83e8326338dc18a347d263b93f-
DA-10149-20180813114911453150